801-797-2297

1414 South 600 West, Bountiful, UT 84010

Mon-Friday, 8am-5pm

801-797-2297 | Mon-Friday, 8am-5pm

Welcome to Our Blog:

Vasolabs News and Education

blog image

New Study: The Effect of a Dietary Supplement Containing Rhamnan Sulfate from Monostroma nitidum on Carotid Atherosclerotic Plaque: A Case Series

February 12, 20243 min read

Vasolabs: Leading the Charge in Heart Health Innovations

In the realm of cardiovascular health, a revolutionary stride has been made, and Vasolabs is at the heart of this breakthrough. We are thrilled to announce our pivotal role in a groundbreaking study, recently published in the esteemed Integrative Medicine journal. This study not only cements our position as leaders in cardiovascular diagnostics but also opens new avenues for preventing and managing heart disease, the leading cause of death in the United States.

The Critical Battle Against Cardiovascular Disease

The shadow of cardiovascular disease (CVD) looms large, claiming more lives annually than any other condition. At the core of CVD lies atherosclerosis—a condition characterized by the buildup of lipid-laden plaques within arterial walls, leading to heart disease and strokes. Despite advancements, the fight against CVD demands innovative approaches, given its complex and multifactorial nature.

A Glimpse into the Groundbreaking Study

Our collaborative efforts with the True Health Center for Functional Medicine have yielded promising results, focusing on the effects of a dietary supplement containing Rhamnan Sulfate (RS) from Monostroma nitidum on carotid atherosclerotic plaque. This case series involved participants who, despite adhering to an integrative regimen for cardiovascular health, showed no improvement in carotid plaque—until the introduction of RS.

The Power of Rhamnan Sulfate

RS, derived from the green seaweed Monostroma nitidum, boasts a plethora of health benefits, including anti-coagulant, antioxidative, and anti-inflammatory properties. Central to our study was its potential to regenerate the endothelial glycocalyx (EGX), a micro-thin layer crucial for vascular health. The deterioration of the EGX marks the onset of atherosclerosis, making it a novel target for therapeutic intervention.

Vasolabs' Contribution and Findings

Utilizing our advanced Carotid Intima-Media Thickness (CIMT) technology, we meticulously measured the plaque burden of participants before and after a six-month regimen of RS supplementation. The results were nothing short of remarkable, showcasing a significant reduction in total plaque burden across the board. This finding not only highlights the efficacy of RS in combating atherosclerosis but also showcases the reliability and clinical utility of CIMT technology in assessing and monitoring cardiovascular health.

Charting a Course for the Future

The implications of this study extend far beyond our current achievements. It underscores the necessity for continued research into RS-based treatments and their integration into cardiovascular disease management. As we forge ahead, our commitment remains unwavering—to revolutionize the diagnosis and treatment of heart disease through innovation and technology.

Embracing the Next Frontier in Heart Health

The journey to conquer heart disease is fraught with challenges, yet filled with opportunities for innovation. At Vasolabs, we are not just participants but pioneers, continually seeking to bridge the gap between current limitations and future possibilities. This study is a testament to our dedication and a beacon of hope for millions at risk of cardiovascular disease.

Join Us in the Fight Against Cardiovascular Disease

We invite healthcare professionals and patients alike to explore the potential of CIMT scanning and RS supplementation as part of a comprehensive approach to cardiovascular health. Together, we can turn the tide against heart disease, armed with knowledge, technology, and the unwavering spirit of innovation.

Conclusion

The battle against cardiovascular disease is far from over, but with each scientific breakthrough, we edge closer to victory. Vasolabs stands at the forefront of this endeavor, embodying the convergence of research, technology, and clinical expertise. Let us embrace this moment as a stepping stone to a future where heart disease no longer claims the lives of our loved ones. Together, we can forge a path to a healthier tomorrow.

Vasolabs

Vasolabs

Back to Blog

Why should you get this C-IMT scan?

Informed patients make better decisions.

hearth Disease Risk

Early Detection of Heart Disease Risk

A C-IMT scan can act as an early warning system by identifying increased thickness in the artery walls long before any symptoms of heart disease or stroke become evident.

Personalized Treatment Plan

Personalized Treatment Plan

The results of a C-IMT scan can help your doctor tailor a treatment plan to reduce your risk of heart attack or stroke, which is the leading cause of death and disability in the world.

Non-Invasive and Safe

Non-Invasive and Safe

Unlike some other tests, the C-IMT scan is non-invasive and uses ultrasound, not radiation. It's safe and doesn't require any special preparation.

Family History

Family History

If you have a family history of early heart disease or stroke, the scan can provide valuable information about your own risk, helping you and your doctor to take preventive measures.

Peace of Mind

Peace of Mind

If you are anxious about your cardiovascular health, a vasometric scan can provide reassurance if your results are within a normal range.

Vasolabs Is A Premier Provider Of Safe, Convenient Heart Disease Screenings.

Vasolabs Is A Premier Provider Of Safe, Convenient Heart Disease Screenings.

  • Uses the newest ultrasound technology

  • Determines whether or not you have heart disease

  • Pain-free. Requires no wires, treadmills, or needles.

  • Takes only 15 minutes

  • Get your Easy-to-Understand Report within 24 hours

  • Optional Discussion with your Clinician

Schedule a test to see if you’re at risk of heart disease!

Identify Your Risks of Getting Cardiovascular Disease With a Simple C-IMT Scan!

Know if You Are at Risk for Heart Attacks, Strokes, and other Cardiovascular Diseases:

$499 $199

What's Included in your Report:

  • See your Vascular Age!

  • Soft or Calcified Plaque is visualized, you’ll see it all.

  • Track Your inflammation, Know your Artery Blockage.

  • Informed patients make better decisions.

Loved ones depend on you.

Do I Need a Heart Screening?

Here is a checklist of factors that put you at elevated risk for heart attack, stroke, and other forms of cardiovascular disease:

  • Over 40 years of age

  • Family history of heart disease/stroke

  • Overweight

  • Increased cholesterol level

  • High-fat diet

  • Tobacco user

  • High blood pressure

  • Diabetic

  • Metabolic syndrome

  • Erectile dysfunction

  • Psoriasis

Peace of Mind is Priceless

Looking back, it's chilling to realize how close I came to the edge. I opted for a test at Vasolabs on a whim, without any particular symptoms. Boy, am I glad I did! Turns out, my arteries were nearly clogged up - something regular doctors wouldn't have caught unless there were signs of a problem. By the time I got a couple of second opinions and returned to my regular doctor, my arteries were 95% blocked. If I hadn't taken the test when I did, I could have had a stroke. Trust me when I say this, going to Vasolabs was one of the best decisions I've ever made.

- George B

I was really worried about getting a heart attack because its already happened in our family. So taking this test gave me the peace of mind I was looking for. And it was so cool to see the age of my artery was younger than I was!!

- Barbara L.

I went to Vasolabs for their C-IMT testing, thinking it'd be a complicated deal, but nope! It was as easy as getting a photo taken. And guess what? They found an issue that could've been a silent threat. Thanks to them catching it early, my doctor and I are on top of it now. Honestly, I feel like I dodged a bullet. Big thumbs up for Vasolabs!

- Walter S.

I saw an ad on Facebook and I got the C-IMT Test for myself and my husband, it was such an easy process. And a great gift idea for family. It was really fun to look at the results and good to know I need to work on my health.

- Jessica F.

Frequently Asked Question

What is a C-IMT scan?

A C-IMT Scan is a non-invasive procedure that uses ultrasound technology to measure the thickness of your carotid arteries' walls. These arteries, located on each side of your neck, supply blood to your brain. Over time, plaque can build up in these arteries, causing them to thicken. This is often an early sign of atherosclerosis, a disease that can lead to serious conditions such as heart attacks and strokes.

Where do I go to get this scan?

For your quick, 15-minute appointment, simply head over to our facility located at 1414 South 600 West, Bountiful, UT 84010.

Who takes my test?

Dean Ence, an expert sonographer, will be handling your fast, no-pain test to figure out the 'age' of your arteries. This test checks how thick your artery walls are - thicker walls can mean inflammation. It's all simplified for you to understand easily. We also spot and show plaque, whether soft or hard, in your arteries. You get detailed pictures from the ultrasound for your records. Taking care of your health is our main goal!

How long does the C-IMT Scan and Report take?

The duration of the C-IMT scan can vary depending on various factors, like the complexity of the patient's condition. Typically, a Vasometric scan takes around 15 minutes to complete. The report is done and delivered within 24 hours to you.

Will my insurance cover this C-IMT Scan?

Most insurance providers don't cover the cost of this scan. However, most hospitals are around $800 a scan, but we are only charging $199!

Hospitals often inflate prices due to the complex nature of their billing systems and agreements with insurance companies.

Our Mission:
Vasolabs is dedicated to promoting heart health by providing innovative, easy-to-access tests. We empower people with insights into their vascular health for early risk detection.